# FDA recall D-0468-2024

> **Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.** · Class III · drug recall initiated 2024-04-09.

## Product

Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13

## Reason for recall

Cross Contamination with Other Products

## Distribution

USA nationwide.

## Key facts

- **Recall number:** D-0468-2024
- **Recalling firm:** Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-04-09
- **Report date:** 2024-05-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Tokushima, N/A, Japan

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0468-2024

## Citation

> AI Analytics. FDA recall D-0468-2024. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0468-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*